Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF – Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $11.64 and last traded at $11.64, with a volume of 7500 shares traded. The stock had previously closed at $11.64.
Ono Pharmaceutical Price Performance
The firm’s 50-day simple moving average is $13.83 and its 200-day simple moving average is $14.08.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Further Reading
- Five stocks we like better than Ono Pharmaceutical
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- The 3 Best Blue-Chip Stocks to Buy Now
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Health Care Stocks Explained: Why You Might Want to Invest
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
